Guidelines for good pharmacoepidemiology practices (GPP)-Reference-Cited by-同舟云学术

Guidelines for good pharmacoepidemiology practices (GPP)

Published:2007-09-17 Issue:2 Volume:17 Page:200-208
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidem. Drug Safe.

Author:

ISPE

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Reference2 articles.

1. Guidelines for good epidemiology practices for occupational environmental epidemiologic research;Chemical Manufacturers Association's Epidemiology Task Group;J Occup Med,1991

2. Guidelines of the National Heart, Lung, and Blood Institute Working Group on Blood Drawing, Processing, and Storage for Genetic Studies;Austin;Am J Epidemiol,1996

Cited by 188 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Four-Strata Risk Assessment in Patients with Pulmonary Arterial Hypertension Treated with Selexipag in Real-World Settings (EXPOSURE Study);Advances in Therapy;2024-07-31

2. A Canadian real world prospective observational study assessing the impact of hormone therapy ± targeted therapy in the treatment of HR+ HER2- advanced breast cancer;2024-07-23

3. Selexipag in patients with pulmonary arterial hypertension associated with connective tissue disease (PAH‐CTD): Real‐world experience from EXPOSURE;Pulmonary Circulation;2024-07

4. Lutetium [177Lu]-DOTA-TATE in gastroenteropancreatic-neuroendocrine tumours: rationale, design and baseline characteristics of the Italian prospective observational (REAL-LU) study;European Journal of Nuclear Medicine and Molecular Imaging;2024-05-22

5. Macitentan in Pulmonary Arterial Hypertension Associated with Connective Tissue Disease (CTD-PAH): Real-World Evidence from the Combined OPUS/OrPHeUS Dataset;Cardiology and Therapy;2024-03-07